|
|
Researchers did what others thought was not possible by finding a small molecule to stop 'slippery' protein from binding to another, causing Ewing's Sarcoma Washington, DC - In a discovery that rebuffs conventional scientific thinking, researchers at Georgetown University Medical Center (GUMC) have discovered a novel way to block the activity of the fusion protein responsible for Ewing's sarcoma, a rare cancer found in children and young adults. In the paper published online July 5 in Nature Medicine, they report discovering and successfully testing a small molecule that keeps the fusion protein from sticking to another protein that is critical for tumor formation. The researchers say this interaction is unique - and is especially surprising since the Ewing's sarcoma fusion protein is extremely flexible, which allows it to... [read full story]
7thspace.com (UK) Taken by mouth, it can be abused or used as a date-rape drug. But 4-HB also called gamma hydroxybutyrate or GHB is best known and most feared when it is taken orally, because it is a drug that impairs the...
Portfolio.com India linking climate change commitments to energy security Hindu Washington: With Indian negotiators working overtime with their American counterparts to have an agreement on arrangements for fuel reprocessing,...
Dell.ca continues to push out some solid desktop PC offers with Intel's new Core i7 processors. At the moment, there's a Vostro 430 Desktop PC with a Core i7-860 processor, 4GB RAM, and Windows 7 Home Premium to be had for $799...
The anti-aging industry is offering a dizzying array of hormones and supplements. Rothenberg put Benedict on a $10,000-a-year regimen of 30 vitamins and supplements, plus testosterone gel and injections of human growth hormone....
